Log In
Print
BCIQ
Print
Print this Print this
 

APL-130277

  Manage Alerts
Collapse Summary General Information
Company Cynapsus Therapeutics Inc.
DescriptionSublingual thin film strip formulation of apomorphine, a small molecule dopamine receptor agonist
Molecular Target Dopamine receptor
Mechanism of ActionDopamine receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat "off " motor symptoms of Parkinson's disease; Treat Parkinson's disease (PD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$4.4M

0

$3.9M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today